Effects of 5-fluorouracil and leucovorin in spheroids: a model for solid tumours
Erlichman, C.; Wu, A.
Anticancer Research 11(2): 671-675
1991
ISSN/ISBN: 0250-7005 PMID: 2064321 Document Number: 368489
We determined the cytotoxicity of 5FU alone or with leucovorin in MGH-H1 cells growing as monolayers or spheroids. The 5FU IC50 in spheroid and monolayers was 100 .mu.M in both culture systems. The IC50 of 5FU and 5FU and 100 .mu.M leucovorin in spheroids and monolayers was 100 .mu.M and 50 .mu.M, respectively. [H3]5FU reached cells at all depths of the spheroid viable rim. Cells isolated from increasing depths of the spheroid viable rim demonstrated increasing resistance to 5FU. 5FU cytotoxicity is increased by leucovorin in monolayer but not spheroids, penetration is not limiting in 5FU cytotoxicity in spheroids and there is increasing resistance to 5FU in the viable rim.
Document emailed within 1 workday
Related Documents
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Yuasa, C.; Okabe, H.; Toko, T.; Takeda, S.; Unemi, N. 1995: Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(13): 1927-1932
Okabo, S.; Arai, T.; Maruyama, S.; Lee, M.; Murase, N.; Tsubaki, M.; Endo, M.; Wada, Y.; Shimoju, K.; Sakurazawa, K.; Sugihara, K.; Maruyama, M.; Yabata, E.; Kawasaki, T.; Sasaki, T. 1997: A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 849-854
Yee, L.K.; Allegra, C.J.; Steinberg, S.M.; Grem, J.L. 1992: Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a Journal of the National Cancer Institute 84(23): 1820-1825
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Grem, J.L.; Shoemaker, D.D.; Petrelli, N.J.; Douglass, H.O. 1987: Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma Cancer Treatment Reports 71(11): 1122
Hahn, E.G.; Gauss-Müller, V.; Hornberger, M.; Kalbfleisch, H.; Deinhardt, F. 1982: Solid tumours of human primary hepatocellular carcinoma cell-lines in hypothymic mice: a model for biochemical and therapeutic studies Zeitschrift für Gastroenterologie 20(3): 168-173
Chevillard, S.; Vielh, P.; Validire, P.; Marie, J.P.; Faussat, A.M.; Barbu, V.; Bayle, C.; Bénard, J.; Bonnal, C.; Boutonnat, J.; Calvo, F.; Charrier, J.; Clary, A.; Colosetti, P.; Danel-Moore, L.; Decrémoux, P.; Delvincourt, C.; Finat-Duclos, F.; Genne, P.; Kataki, A.; Kouyoumdjian, J.C.; Lacave, R.; Maugard, C.; Merlin, J.L.; Robert, J. 1997: French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris Leukemia 11(7): 1095-1106
Mulder, P.O.; Schröder, P.; de Vries-Hospers, H.G.; van der Geest, S.; Sleijfer, D.T.; Mulder, N.H.; de Vries, E.G. 1989: Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumours Netherlands Journal of Medicine 34(3-4): 126-131
Allegra, C.J.; Egan, G.F.; Drake, J.C.; Steinberg, S.M.; Swain, S.M. 1988: The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin Advances in Experimental Medicine and Biology 244: 107-112
Aiba, K. 1988: Biochemical modulation of 5-fluorouracil by high-dose leucovorin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 392-408
Bruckner, H.W.; Spigelman, M. 1988: Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy Mount Sinai Journal of Medicine new York 55(5): 390-394
Hehr, T.; Adamek, H.E. 2002: Value of postoperative radiochemotherapy with 5-fluorouracil plus leucovorin in stage IB-IV M0 stomach carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 178(3): 164-166
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Fukunaga, T.; Aihara, N. 2003: Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(13): 2077-2081
Klubes, P.; Connelly, K.; Cerna, I.; Mandel, H.G. 1978: Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors Cancer Research 38(8): 2325-2331
Terashima, M.; Ikeda, K.; Kawamura, H.; Maesawa, C.; Takiyama, I.; Yoshinari, H.; Koeda, K.; Sato, N.; Ishida, K.; Saito, K. 1992: Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 1999-2004
Baur, M.; Schlappack, O.; Havelec, L.; Mader, R.; Marosi, C.; Scheithauer, W.; Dittrich, C. 1991: 5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma Wiener Klinische Wochenschrift 103(11): 332-339
Kobayashi, R.; Yoshimatsu, K.; Yokomizo, H.; Katsube, T.; Ogawa, K. 2007: Low-dose chemotherapy with leucovorin plus 5-fluorouracil for colorectal cancer can maintain host immunity Anticancer Research 27(1b): 675-679
Yokomizo, H.; Yoshimatsu, K.; Hashimoto, M.; Ishibashi, K.; Umehara, A.; Yoshida, K.; Fujimoto, T.; Watanabe, K.; Ogawa, K. 2004: Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis Anticancer Research 24(2c): 1131-1134